BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24153406)

  • 1. Cell culture process operations for recombinant protein production.
    Abu-Absi S; Xu S; Graham H; Dalal N; Boyer M; Dave K
    Adv Biochem Eng Biotechnol; 2014; 139():35-68. PubMed ID: 24153406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equipment for large-scale mammalian cell culture.
    Ozturk SS
    Adv Biochem Eng Biotechnol; 2014; 139():69-92. PubMed ID: 24429549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches to optimizing animal cell culture process: substrate metabolism regulation and protein expression improvement.
    Zhang Y
    Adv Biochem Eng Biotechnol; 2009; 113():177-215. PubMed ID: 19373452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of insect cell based protein production processes - online monitoring, expression systems, scale up.
    Druzinec D; Salzig D; Brix A; Kraume M; Vilcinskas A; Kollewe C; Czermak P
    Adv Biochem Eng Biotechnol; 2013; 136():65-100. PubMed ID: 23995041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fed-batch and perfusion culture processes: economic, environmental, and operational feasibility under uncertainty.
    Pollock J; Ho SV; Farid SS
    Biotechnol Bioeng; 2013 Jan; 110(1):206-19. PubMed ID: 22806692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
    Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
    J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manufacturing of recombinant therapeutic proteins in microbial systems.
    Graumann K; Premstaller A
    Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrated fed-batch cell culture increases manufacturing capacity without additional volumetric capacity.
    Yang WC; Minkler DF; Kshirsagar R; Ryll T; Huang YM
    J Biotechnol; 2016 Jan; 217():1-11. PubMed ID: 26521697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single pass tangential flow filtration to debottleneck downstream processing for therapeutic antibody production.
    Dizon-Maspat J; Bourret J; D'Agostini A; Li F
    Biotechnol Bioeng; 2012 Apr; 109(4):962-70. PubMed ID: 22094920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of dynamic online fed-batch strategies on metabolism, productivity and N-glycosylation quality in CHO cell cultures.
    Chee Furng Wong D; Tin Kam Wong K; Tang Goh L; Kiat Heng C; Gek Sim Yap M
    Biotechnol Bioeng; 2005 Jan; 89(2):164-77. PubMed ID: 15593097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian cell line developments in speed and efficiency.
    Estes S; Melville M
    Adv Biochem Eng Biotechnol; 2014; 139():11-33. PubMed ID: 24196317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of a mammalian cell culture process by adaptive, model-based dialysis fed-batch cultivation and suppression of apoptosis.
    Frahm B; Lane P; Märkl H; Pörtner R
    Bioprocess Biosyst Eng; 2003 Nov; 26(1):1-10. PubMed ID: 14505167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-free fed-batch culture of non-GS NS0 cell lines for production of recombinant antibodies.
    Burky JE; Wesson MC; Young A; Farnsworth S; Dionne B; Zhu Y; Hartman TE; Qu L; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):281-93. PubMed ID: 16933323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated continuous production of recombinant therapeutic proteins.
    Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
    Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfusion cell culture for the production of conjugated recombinant fusion proteins reduces clipping and quality heterogeneity compared to batch-mode processes.
    Bielser JM; Chappuis L; Xiao Y; Souquet J; Broly H; Morbidelli M
    J Biotechnol; 2019 Aug; 302():26-31. PubMed ID: 31207262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of quality by design principles to the development and technology transfer of a major process improvement for the manufacture of a recombinant protein.
    Looby M; Ibarra N; Pierce JJ; Buckley K; O'Donovan E; Heenan M; Moran E; Farid SS; Baganz F
    Biotechnol Prog; 2011; 27(6):1718-29. PubMed ID: 21948302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Operator training in recombinant protein production using a structured simulator model.
    Gerlach I; Brüning S; Gustavsson R; Mandenius CF; Hass VC
    J Biotechnol; 2014 May; 177():53-9. PubMed ID: 24630856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of selected control strategies for fed-batch cultures of a hybridoma cell line.
    Pörtner R; Schwabe JO; Frahm B
    Biotechnol Appl Biochem; 2004 Aug; 40(Pt 1):47-55. PubMed ID: 15270707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated dynamic fed-batch process and media optimization for high productivity cell culture process development.
    Lu F; Toh PC; Burnett I; Li F; Hudson T; Amanullah A; Li J
    Biotechnol Bioeng; 2013 Jan; 110(1):191-205. PubMed ID: 22767053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing mammalian cell culture engineering using genome-scale technologies.
    Griffin TJ; Seth G; Xie H; Bandhakavi S; Hu WS
    Trends Biotechnol; 2007 Sep; 25(9):401-8. PubMed ID: 17681628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.